The Newsroom    Published Thursday, May. 23, 2013, 11:14 AM
Print   |   
« Back   |   

Given PillCam Seen Winning FDA Approval in ’13: Israel Overnight

Washington Post, May 22, 2013

UTMB’s Dr. James Goodwin is cited in this Bloomberg report: Results from Given Imaging Ltd.’s latest clinical study of a pill-sized camera used to identify colon cancer probably will help the Israeli manufacturer secure U.S. regulatory approval this year. Physicians can detect pre-cancerous tumors with PillCam Colon, a capsule-sized camera that’s comparable to a colonoscopy. Pricing of the PillCam Colon will be about $500 per capsule. Colonoscopies can cost $800 to $1,200, Dr. James Goodwin told Bloomberg News in March. Inappropriate use of the procedure may cost about $500 million a year for Medicare, the U.S. health program for the elderly and disabled, he said.

 




Follow Us:
The Newsroom is a service provided by the Office of Public Affairs  •  Questions or Comments?